Tirzepatide is a groundbreaking therapeutic agent for individuals facing type 2 diabetes. As a dual stimulator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide https://alvinglhu082889.actoblog.com/41417601/tirzepatide-a-new-frontier-in-diabetes-treatment